CareTrust REIT, Inc. (CTRE)

HealthcareSolid
Back to rankings

Assessment summary

Overall quality score
3.60/ 5
Solid

Investable with eyes open — watch the weaker categories.

Assessed
Aug 7, 2026
Category breakdown
Cash flow & dividend safety4.0/5
Balance sheet4.8/5
Operating performance2.5/5
Portfolio & sector quality2.8/5
Management & capital allocation2.8/5
Valuation5.0/5

Price

$39.37

Yield

3.68%

P/(A)FFO

19.30x

Payout

1.41x

Occupancy

83.9%

Net debt / EBITDA

1.01x

Category scores

Six weighted categories make up the overall quality score. Each renders its own rationale once this name has been through a scoring pass.

Cash flow & dividend safety

Weight 20%
4.0/5

AFFO per share of $0.51 in Q2 2026 represents 19% growth year-over-year ($0.42 in Q2 2025), demonstrating steady growth trajectory. The payout ratio stands at 76% of Normalized FAD, well below the 75% threshold and comfortably within the safety zone. Full-year 2026 guidance projects Normalized FAD of $2.01–$2.04 per share, representing 15.1% growth over 2025, with the dividend maintained at $0.39 quarterly. While the company shows strong current metrics and growth momentum, the data does not yet establish a 10+ year dividend growth streak, preventing a perfect 5 score.

Balance sheet

Weight 20%
4.8/5

CareTrust demonstrates a fortress balance sheet well above the 5-anchor threshold. Net debt-to-EBITDA of 1.01x is substantially below the 5x benchmark, indicating minimal leverage. Coverage is strong with FFO payout ratio of 76% on normalized FAD of $0.51, implying coverage of approximately 1.32x on dividends alone, though the company generates significant excess cash flow. The company has no scheduled debt maturities prior to 2028, $605 million available on a $1.2 billion revolving facility, and actively manages capital through equity forwards and ATM programs. While specific debt composition details are not provided, the low leverage, strong liquidity position, and investment-grade operational metrics suggest a well-laddered, primarily fixed-rate structure typical of investment-grade REITs. The only minor constraint preventing a perfect 5 is the absence of explicit credit rating confirmation and detailed maturity ladder disclosure in the filing excerpt.

Operating performance

Weight 20%
2.5/5

CareTrust shows mixed operating performance against the rubric. Occupancy stands at 83.9%, which falls significantly short of the 95%+ threshold for a score of 5 and below the low-90s range for a score of 3. Normalized FFO per share grew 19% year-over-year to $0.51 in Q2 2026, with full-year 2026 guidance projecting 16.2% FFO growth over 2025, substantially exceeding the +3% SSNOI benchmark. However, the occupancy metric—a core operational indicator—is the primary constraint, placing performance between a score of 2 (shrinking operations) and 3 (stable low-90s), closer to the midpoint given strong FFO growth offsetting occupancy weakness.

Portfolio & sector quality

Weight 15%
2.8/5

CareTrust operates in skilled nursing and seniors housing, a structurally challenged sector facing reimbursement pressure, labor cost inflation, and regulatory headwinds—characteristics anchoring toward the lower end of the rubric. However, the portfolio shows meaningful offsetting strengths: 83.9% occupancy is solid, the company deployed $1.5 billion year-to-date at 8.7% blended yields with a $540 million pipeline, 100% rent collection, and management emphasizes a diversified operator base with high-quality relationships. The 1.01x net debt-to-EBITDA and fortress balance sheet provide stability. The sector itself remains challenged relative to secular-tailwind alternatives, and the company's reliance on healthcare reimbursement creates structural headwinds, but operational execution and portfolio quality partially mitigate these concerns, placing the assessment between stable-but-competitive (3) and challenged (1).

Management & capital allocation

Weight 15%
2.8/5

CareTrust demonstrates mixed capital allocation discipline. Positively, the company achieved 19% FFO per-share growth year-over-year and maintains a conservative 1.01x net debt-to-EBITDA with a 76% payout ratio, indicating disciplined capital deployment. However, the company is actively pursuing external growth through aggressive equity issuance—$578.2 million in forward equity offerings and $363.6 million from ATM settlements in Q2 alone, with $671 million outstanding—which dilutes existing shareholders despite strong per-share growth. Management is self-administered (positive), but the reliance on continuous equity raises to fund $1.5 billion year-to-date in acquisitions at 8.7% yields, combined with guidance assuming no new issuances yet $785.8 million remaining ATM capacity, suggests growth is partly dependent on dilutive issuance rather than purely accretive deployment. Disclosure is candid on liquidity and capital structure, but the pattern reflects external-growth-dependent strategy rather than insider-led per-share value creation.

Valuation

Weight 10%
5.0/5

Mechanical valuation (D-07): current ratio 20.18 vs 27-point own history, percentile rank 0.00.

Score history

Event-anchored

Illustrative history — each point corresponds to a scoring trigger (filing, announcement, or initial coverage). At launch a name has a single point.

Sources

Sources are the exact documents used by this assessment, recorded when it ran.

Metric history

P/(A)FFO

P/(A)FFO over time — 28 data points since Aug 2, 2026.

Scores are analytical opinions, not investment advice. Figures reflect the most recent data available as of the assessed date and may differ from current market values.